Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

LCP-Fortified Formula Reduces Abnormal Infant Movement -Dutch Study

This article was originally published in The Tan Sheet

Executive Summary

Formula fortified with long-chain polyunsaturated fatty acids may bolster neurological development in infants, as measured by abnormal general movements, a study published in the August American Journal of Clinical Nutrition concludes

You may also be interested in...



Martek Stock Climbs 45%; Do Future Gains Lie Beyond Infant Formula?

Martek Biosciences' long-awaited launch of its DHA and ARA nutritional oils in U.S. infant formula has garnered Wall Street's enthusiasm, but continued investor confidence could hinge on the fortified products' commercial success, as well as Martek's ability to expand beyond the infant formula market

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS095792

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel